REFERENCES
- Baldo V, Floreani A, Dal Vecchio L, et al. Occupational risk of bloodborne viruses in healthcare workers: a 5-year surveillance program. Infect Control Hosp Epidemiol 2002; 23: 325–7, [PUBMED], [INFOTRIEVE], [CSA]
- Riddell L A, Sherrard J. Blood-borne virus infection: the occupational risks. Int. J. STD AIDS 2000; 11: 632–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fahey B J, Koziol D E, Banks S M, Henderson D K. Frequency of nonparenteral occupational exposures to blood andbody fluids before andafter universal precautions training. Am. J. Med. 1991; 90: 145–53
- Brillhart A M, Thomas D R, Becker L, Eisenberg M S, Murray J A. Time to first shock by emergency medical technicians with automated external defibrillators. Prehosp Emerg Care 2002; 6: 373–7, [PUBMED], [INFOTRIEVE]
- Centers f or. Disease Control andPrevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, andHIV andrecommendations for postexposure prophylaxis. MMWR 2001; 50(6), Available at: http://www.cdc.gov/mmwr/PDF/RR/RR5011.pdf. Accessed June 24, 2004
- King County Government, Available at: http://www.metrokc.gov/health/medicone/system.htm. Accessed Jun 24, 2004
- AIDS/TB Committee of the Society for Healthcare Epidemiology of America. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect Control Hosp Epidemiol 1997; 18: 349–63, [CSA]
- Beltrami E M, Williams I T, Shapiro C N, Chamberland M E. Risk andmanagement of blood-borne infections in health care workers. Clin Microbiol Rev 2000; 13: 385–407, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cardo D M, Smith D K, Bell D M. Postexposure management. AIDS Therapy, R Dolin, H Masur, M S Saag. Churchill Livingstone, New York, NY 1999; pp 236–47
- Centers f or. Disease Control andPrevention. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996; 45: 468–72
- Centers f or. Disease Control andPrevention. Public Health Service guidelines for the management of health-care worker exposures to HIV andrecommendations for postexposure prophylaxis. MMWR 1998; 47(no. RR–7)
- Centers for Disease Control andPrevention. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, andother bloodborne pathogens in health-care settings. MMWR 1988; 37: 377–82–387–8
- Centers for Disease Control andPrevention. Recommendations for the prevention andcontrol of hepatitis C virus (HCV) infection andHCV-related chronic disease. MMWR 1998; 47(RR-19)1–39
- Department of Labor, Occupational Safety andHealth Administration. 29 CFR Part 1910.1030. Occupational exposure to bloodborne pathogens, needlestick andother sharps injuries; final rule. Fed Reg. 1991; 66: 5317–25
- Gerberding J L. Management of occupational exposures to blood-borne viruses. N Engl. J. Med. 1995; 332: 444–51, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gerberding J L, Henderson D K. Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, andhuman immunodeficiency virus. Clin Inf Dis 1992; 14: 1179–85, [CSA]
- Puro V, Cicalini S, De Carli G, Soldani F, Ippolito G. Towards a standard HIV post exposure prophylaxis for healthcare workers in Europe. Euro. Surveill. 2004; 9(6)3–4
- U.S. Fire Administration. Guide to Managing an Emergency Service Infection Control Program. US FA, Emmitsburg, MD Jan, 2002
- Varghese G M, Abraham O C, Mathai D. Post-exposure prophylaxis for blood borne viral infections in healthcare workers. Postgrad Med J. 2003; 79: 324–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kinloch-De L S, Hirschel B J, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995; 333: 408–13, [CSA], [CROSSREF]
- Niu M T, Stein D S, Schnittmann S M. Primary human immunodeficiency virus type 1 infection: review of pathogenesis andearly treatment interventions in humans andanimal retrovirus infections. J Infect Dis 1993; 168: 1490–501, [PUBMED], [INFOTRIEVE]
- Martin L N, Murphey-Corb M, Soike K F, Davison-Fairburn B, Baskin C. Effects of initiation of 3-axido,3-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Infect Dis 1993; 168: 825–35, [PUBMED], [INFOTRIEVE]
- Niu M T, Stein D S, Schnittmann S M. Primary human immunodeficiency virus one infection: review of pathogenesis andearly treatment intervention in humans andanimal retrovirus infection. J Infect Dis 1993; 168: 1490–501, [PUBMED], [INFOTRIEVE]